Novartis NVS announced that the FDA has approved Fabhalta (iptacopan) for a third indication. The regulatory body approved ...

Researchers who have studied genetic evidence of iguanas suggest the ancient reptiles traveled nearly 5,000 miles from North ...

The FDA approved oral iptacopan (Fabhalta; Novartis) to reduce proteinuria in adults with C3 glomerulopathy (C3G), according ...

Researchers have discovered that an enzyme can serve as an ideal target for developing new therapeutics against Lyme disease, and most likely other tick-borne diseases as well.

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...

Lamellar ichthyosisis one of several types of skin disorders (skin disorder) which is calledichthyosis. Ichthyosisis a term for a severe and persistent dry skin condition that almost always begins in ...

Seventeen-year-old Hamzah has congenital ichthyosis, a disorder that causes hard, scaly skin. It also affects his vision, ...

I became a natural-deodorant user in 2017, when I accidentally bought Arm & Hammer deodorant at the local drugstore thinking it had aluminum in it. As a heavy sweater, I was unimpressed with the ...

"If we have the cure for pancreatic cancer, but only 40% of the public is going to come in and take it because the rest don't trust us, then that medication is only 40% effective," he said. "So I ...

WASHINGTON (AP) — Rural cancer patients may miss out on cutting-edge treatments in Utah. Therapies for intellectual disorders could stall in Maryland. Red states and blue states alike are poised ...